MLICM
TMCI icon

Metropolitan Life Insurance Company (MetLife)’s Treace Medical Concepts TMCI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,790
Closed -$36.4K – 1926
2024
Q1 		$36.4K Hold
2,790
– – ﹤0.01% 1562
2023
Q4 		$35.6K Hold
2,790
– – ﹤0.01% 1619
2023
Q3 		$36.6K Buy
2,790
+296
+12% +$5.42K ﹤0.01% 1572
2023
Q2 		$63.8K Buy
2,494
+545
+28% +$14.1K ﹤0.01% 1283
2023
Q1 		$49.1K Sell
1,949
-337
-15% -$7.91K ﹤0.01% 1404
2022
Q4 		$52.6K Hold
2,286
– – ﹤0.01% 1440
2022
Q3 		$50.5K Hold
2,286
– – ﹤0.01% 1458
2022
Q2 		$32.8K Hold
2,286
– – ﹤0.01% 1762
2022
Q1 		$43.2K Sell
2,286
-6,788
-75% -$132K ﹤0.01% 1678
2021
Q4 		$169K Buy
9,074
+5,059
+126% +$104K ﹤0.01% 2141
2021
Q3 		$108K Hold
4,015
– – ﹤0.01% 2483
2021
Q2 		$126K Buy
+4,015
New +$128K ﹤0.01% 2474

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TMCI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 2,790 shares — an estimated $36.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $169K in Q4 2021. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,790 Treace Medical Concepts shares in Q2 2024, an estimated $36.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Treace Medical Concepts position peaked at $169K in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.